Fractyl Health to Make Presentation at BofA Securities 2024 Health Care Conference
Health

Revolutionizing Metabolic Disease Treatment: Fractyl Health’s Fireside Chat at BofA Securities 2024 Health Care Conference

Eleanor Thompson

Fractyl Health is a metabolic therapeutics company that specializes in innovative approaches to treating obesity and type 2 diabetes (T2D). The company’s CEO, Dr. Harith Rajagopalan, will be participating in a fireside chat at the upcoming BofA Securities 2024 Health Care Conference on May 15, 2024, at 4:20 p.m. PDT (7:20 p.m. EDT). To register for the webcast of the fireside chat, visit the company’s website.

Fractyl Health is dedicated to developing new treatments for metabolic diseases like obesity and T2D. Despite advancements in treatment, these diseases continue to pose significant health risks. The company’s mission is to shift the focus of metabolic disease treatment from managing symptoms to providing long-lasting therapies that target the root causes of the diseases. Fractyl Health is headquartered in Burlington, MA. For more information about the company, visit their website or follow them on Twitter.

For corporate inquiries, contact Lisa Davidson, Chief Financial Officer at ir@fractyl.com or 781.902.8800

Leave a Reply

Expion Health improves its RFP process using AI Previous post Revolutionizing the Prescription Cost Management Process: ExpionIQ Advisor Uses AI to Automate RFPs and Reduce Error Rates
US retailers lag behind in adopting HFC-free technology Next post HFC-Free Refrigeration Lags Behind in Supermarkets: Report Calls Out Major Chains for Poor Performance

More Stories